On February 22, 2021 Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, reported that investors and the general public to listen to webcasts at the following investor conferences (Press release, Myovant Sciences, FEB 22, 2021, https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-present-upcoming-investor-conferences-2 [SID1234575389]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 at 3:40 p.m. Eastern Time. David Marek, Chief Executive Officer of Myovant Sciences, Inc., and Frank Karbe, President and Chief Financial Officer of Myovant Sciences, Inc., will participate in a fireside chat. Management will also participate in one-on-one investor meetings on February 25.

Cowen 41st Annual Health Care Conference on March 2, 2021 at 11:10 a.m. Eastern Time. Mr. Marek and Mr. Karbe will participate in a fireside chat. Management will also participate in one-on-one investor meetings on March 2.
The presentations will be accessible on the Events page under the Investors & Media section of the Myovant website at www.myovant.com.